CITIC Capital has increased its stake in Harbin Pharmaceutical Group to 60.86%, becoming the controlling shareholder of the Chinese state-backed business in which it has been an investor since 2005.
Harbin Pharmaceutical was the GP's first state-owned enterprise (SOE) restructuring deal. In 2005, it partnered with Warburg Pincus and local PE firm Heilongjiang Chenergy Hit High-Tech Venture Capital...
Hitachi has agreed to sell its Japan-based radiation measurement devices and industrial x-ray CT devices businesses to local private equity firm Nippon Mirae Capital.
MBK Partners has agreed to buy five ocean theme parks in China – four operational and one under construction – from Hong Kong-listed Haichang Ocean Park Holdings for RMB6.53 billion ($1.01 billion).
Trustar Capital, formerly known as CITIC Capital Partners, has invested an undisclosed sum in Intramco, a Europe-based manufacturer of components used in electric vehicle (EV) charging.
Vitalbridge Capital, a China-based venture capital firm that spun out from Trustbridge Partners, has raised $275 million for its second US dollar-denominated fund.